Table 2 Comparison of factors associated with 15-day mortality.
Healthy controls (n = 37) | Submassive PE (n = 37) | Massive PE (n = 37) | Mann-Whitney U-test (Massive vs Submassive PE) | Massive PE Survivors (n = 19) | Massive PE Non-survivors (n = 18) | Mann-Whitney U-test (Non-survivors vs Survivors) | ||
|---|---|---|---|---|---|---|---|---|
Troponin I (ng/ml) | 0.003 (0.001-0.005) | 0.009 (0.006-0.012) | 0.019 (0.012-0.028) | -3.040 p <0.002 | 0.016 (0.012-0.023) | 0.023 (0.014-0.28) | -2.042 p <0.04 | |
D- dimer (μg/ml) | 0.5 (0.1-0.8) | 7.8 (4.1-10.4) | 12.6 (8.2-15.8) | -2.309 p <0.021 | 11.9 (8.2-15.3) | 13.7 (10.6-15.8) | -1.004 NS | |
NT-proBNP (pg/ml) | 235 (130-350) | 570 355-840 | 1720 (770-3185) | -2.750 p <0.006 | 1510 (770-2140) | 1940 (950-3185) | -1.332 NS | |
H-FBAP (ng/ml) | 1.4 (0.8-2.1) | 3.1 (1.6-4.2) | 6.8 (5.7-7.8) | -3.520 p <0.001 | 6.4 (5.7-7.4) | 7.3 (6.1-7.8) | -2.839 p <0.05 | |
Plasma n- DNA (GE/ml) | 520 (230-760) | 1245 (680-2315) | 3325 (1080-5790) | -3.039 p <0.002 | 2285 (1280-4010) | 4450 (1130-5780) | -2.750 p <0.016 | |
Plasma mt- DNA (GE/ml) | 185 (70-430) | 870 (365-1690) | 2970 (1050-5485) | -4.151 p <0.000 | 1830 (1050-3215) | 4220 (2110-5510) | -3.769 p <0.001 | |
Plasma sFas (pg/ml) | 1070 (530-1650) | 3355 (640-6720) | 8940 (5330-13270) | -2.408 p <0.013 | 7680 (6330-9400) | 10570 (9050-12870) | -2.355 p <0.019 | |
Plasma sFasL (pg/ml) | 460 (355-540) | 510 (285-580) | 790 (570-920) | -1.265 NS | 755 (570-845) | 810 (640-920) | -1.265 NS |